The effect of enzyme therapy in a patient with Gaucher disease type III

被引:3
|
作者
Bosman, DK
Hollak, CEM
Aerts, JMFG
Bakker, HD
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,EMMA CHILDRENS HOSP,NL-1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT INTERNAL MED,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT BIOCHEM,NL-1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF01799852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
下载
收藏
页码:703 / 704
页数:2
相关论文
共 50 条
  • [1] Enzyme replacement therapy in a patient with type III Gaucher disease
    Carbajal-Rodriguez, Luis
    Gomez-Gonzalez, Ma. Fernanda
    Rodriguez-Herrera, Raymundo
    Zarco-Roman, Jorge
    Mora-Tiscareno, Ma. Antonieta
    ACTA PEDIATRICA DE MEXICO, 2012, 33 (01): : 9 - 19
  • [2] Enzyme replacement therapy in type III Gaucher disease
    Tylki-Szymanska, A
    Czartoryska, B
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) : 203 - 204
  • [3] Enzyme replacement therapy in a patient with type III Gaucher disease: Report of a paradigmatic case
    Vairo, Filippo
    Dorneles, Alicia
    Mittelstadt, Suzana
    Wilke, Matheus
    Doneda, Divair
    Netto, Cristina
    Schwartz, Ida
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S94 - S95
  • [4] Pulmonary involvement in patient with Gaucher disease type III after 4 years of enzyme replacement therapy
    Djordjevic, M.
    Minic, P.
    Djuricic, S.
    Djokic, D.
    Sarajlija, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 119 - 119
  • [5] Pulmonary disease in type III Gaucher disease refractory to conventional enzyme replacement therapy
    Davison, James E.
    Wallis, Colin
    Mauri, Francesco
    Berry, Matthew
    Vellodi, Ashok
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S34 - S35
  • [6] Outcome of type III Gaucher disease on enzyme replacement therapy: Review of 55 cases
    Davies, E. H.
    Erikson, A.
    Collin-Histed, T.
    Mengel, E.
    Tylki-Szymanska, A.
    Vellodi, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (06) : 935 - 942
  • [7] Enzyme replacement therapy in type 2 Gaucher disease
    Tournay, A
    Parker, C
    Schiffman, R
    Brady, R
    Barton, N
    NEUROLOGY, 1996, 46 (02) : 1106 - 1106
  • [8] Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease
    Wenstrup, Richard J.
    Kacena, Katherine A.
    Kaplan, Paige
    Pastores, Gregory M.
    Prakash-Cheng, Ainu
    Zimran, Ari
    Hangartner, Thomas N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (01) : 119 - 126
  • [9] Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy
    Dobbelaere, D
    Sukno, S
    Defoort-Dhellemmes, S
    Lamblin, MD
    Largillière, C
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (01) : 74 - 76
  • [10] No justification for very high-dose enzyme therapy for patients with type III Gaucher disease
    Zimran, Ari
    Elstein, Deborah
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (06) : 843 - 844